Jane Street
RNTX

Jane Street’s Rein Therapeutics RNTX Stock Holding History

Jane Street’s Portfolio RNTX Stock Details RNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-61,960
Closed -$71.9K – 13380
2025
Q4 		$71.9K Buy
+61,960
New +$85.4K ﹤0.01% 10359
2022
Q3 		– Sell
-3,792
Closed -$20K – 10644
2022
Q2 		$20K Buy
3,792
+2,049
+118% +$18.8K ﹤0.01% 9164
2022
Q1 		$18K Sell
1,743
-393
-18% -$3.56K ﹤0.01% 9968
2021
Q4 		$24K Buy
+2,136
New +$33K ﹤0.01% 9759

Other funds holding RNTX

VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Jane Street's RNTX Position: Q1 2026 in Review

Jane Street sold out of Rein Therapeutics (RNTX) in Q1 2026, closing a stake of 61,960 shares — an estimated $71.9K sold.

Jane Street first reported a position in RNTX in Q4 2021 and held it in 4 quarters. The position peaked at $71.9K in Q4 2025. 46 funds tracked by Wall St. Rank hold RNTX as of Q1 2026.

  • Jane Street reported no remaining Rein Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 61,960 Rein Therapeutics shares in Q1 2026, an estimated $71.9K.
  • Jane Street first reported a position in Rein Therapeutics in Q4 2021 and held it in 4 quarters.
  • Jane Street's Rein Therapeutics position peaked at $71.9K in Q4 2025.
  • 46 funds tracked by Wall St. Rank held Rein Therapeutics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.